ITEMS IN AFP WITH KEYWORD:

Osteoporosis

Feb 15, 2010 Issue
Combination Therapy for Postmenopausal Osteoporosis [FPIN's Clinical Inquiries]

There is insufficient evidence to recommend combination therapy for the routine management of postmenopausal osteoporosis.


May 1, 2009 Issue
ACP Releases Guideline on Treatment of Low Bone Mineral Density or Osteoporosis to Prevent Fractures [Practice Guidelines]

The American College of Physicians (ACP) recently released guidelines on treatment of low bone mineral density (BMD) or osteoporosis to prevent fractures describes the available evidence on pharmacologic treatment in men and women.


Feb 1, 2009 Issue
Osteoporosis Screening: Mixed Messages in Primary Care [Editorials]


Feb 1, 2009 Issue
Diagnosis and Treatment of Osteoporosis [Article]

Osteoporosis affects approximately 8 million women and 2 million men in the United States. The associated fractures are a common and preventable cause of morbidity and mortality in up to 50 percent of older women. The U.S. Preventive Services Task Force recommends using dual energy x-ray absorptiome...


Oct 1, 2008 Issue
ACP Guidelines on Screening for Osteoporosis in Men [Practice Guidelines]

Guidelines on screening for osteoporosis in men are available from the American College of Physicians (ACP). Although osteoporosis is commonly thought of as a disease that affects women, osteoporotic fractures also result in considerable morbidity and mortality in men.


Sep 1, 2008 Issue
Alendronate for Fracture Prevention in Postmenopause [Cochrane for Clinicians]

In postmenopausal women, a 10-mg daily dose of alendronate is effective for secondary (number needed to treat [NNT] = 16) and primary (NNT = 50) prevention of vertebral fractures. It is also effective for secondary prevention of nonvertebral fractures, including hip or wrist fractures (NNT = 100), b...


Aug 15, 2008 Issue
Zoledronic Acid (Reclast) for Osteoporosis [STEPS]

Zoledronic acid, in combination with calcium and vitamin D, will reduce the risk of vertebral fractures, and to a lesser extent, hip fractures in women with osteoporosis. It decreases subsequent fractures and mortality in high-risk patients who have had a hip fracture. Zoledronic acid may be most us...


Jul 15, 2007 Issue
Predicting Hip Fracture Risk in Older Women [Point-of-Care Guides]

Approximately one in six women will have a hip fracture during her lifetime, and approximately one in 35 of all women will die of complications from hip fracture.


Nov 1, 2006 Issue
NAMS Updates Recommendations on Diagnosis and Management of Osteoporosis in Postmenopausal Women [Practice Guidelines]

The North American Menopause Society (NAMS) has updated its evidence-based guidelines on the diagnosis, prevention, and treatment of osteoporosis in postmenopausal women to address the need for standards of care as they relate to menopause-associated health conditions.


Jan 15, 2006 Issue
Ibandronate (Boniva) for Treatment and Prevention of Osteoporosis in Postmenopausal Women [STEPS]

Ibandronate is a bisphosphonate that can be taken daily or monthly. The daily dosage has been shown to decrease vertebral fractures in women with osteoporosis and a history of previous vertebral fractures. Neither formulation has been shown to reduce the risk of hip fracture or other nonvertebral fr...


Pages: Previous 1 2 3 4 5 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now